Andy Weymann is a qualified orthopaedic surgeon in trauma and sports medicine. He is also on the Board of Directors is the CEO at Gelmetix, as well on the board of inno4ortho, and is the Senior Medical Advisor of Jellagen, Hyalex Orthopedics, and 30 Technology.
Prior to joining VirtaMed, Andy spent 13 years as Chief Medical Officer Smith+Nephew where he provided global leadership and oversight of the Scientific, Clinical, and Medical Affairs, with accountability for market and business development. Before he was leading AO Education for over 10 years training orthopedic, spine, and Craniomaxillofacial Surgeons globally.